The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Pseudomonas Aeruginosa: Resistance to the Max
Open accessAbstract
Pseudomonas aeruginosa is intrinsically resistant to a variety of antimicrobials and can develop resistance during anti-pseudomonal chemotherapy both of which compromise treatment of infections caused by this organism. Resistance to multiple classes of antimicrobials (multidrug resistance) in particular is increasingly common in P. aeruginosa, with a number of reports of pan-resistant isolates treatable with a single agent, colistin. Acquired resistance in this organism is multifactorial and attributable to chromosomal mutations and the acquisition of resistance genes via horizontal gene transfer. Mutational changes impacting resistance include upregulation of multidrug efflux systems to promote antimicrobial expulsion, derepression of ampC, AmpC alterations that expand the enzyme's substrate specificity (i.e., extended-spectrum AmpC), alterations to outer membrane permeability to limit antimicrobial entry and alterations to antimicrobial targets. Acquired mechanisms contributing to resistance in P. aeruginosa include β-lactamases, notably the extended-spectrum β-lactamases and the carbapenemases that hydrolyze most β-lactams, aminoglycoside-modifying enzymes, and 16S rRNA methylases that provide high-level pan-aminoglycoside resistance. The organism's propensity to grow in vivo as antimicrobial-tolerant biofilms and the occurrence of hypermutator strains that yield antimicrobial resistant mutants at higher frequency also compromise anti-pseudomonal chemotherapy. With limited therapeutic options and increasing resistance will the untreatable P. aeruginosa infection soon be upon us?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Antibiotic resistance of bacterial biofilms
Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S., & Ciofu, O. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.011 · Cited by 3,225
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
beta-Lactamases in laboratory and clinical resistance
Livermore, D. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.557 · Cited by 1,779
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria
Hall, C. W., & Mah, T.-F. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux010 · Cited by 1,696
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
Moradali, M. F., Ghods, S., & Rehm, B. H. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00039 · Cited by 1,537
Pseudomonas aeruginosa : new insights into pathogenesis and host defenses
Gellatly, S. L., & Hancock, R. E. W. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12033 · Cited by 1,295
Horcajada, J. P., Montero, M., Oliver, A., Sorlí, L., Luque, S., Gómez-Zorrilla, S., Benito, N., & Grau, S. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-19 · Cited by 961
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
Chan, B. K., Sistrom, M., Wertz, J. E., Kortright, K. E., Narayan, D., & Turner, P. E. (2016) · Scientific Reports · doi:10.1038/srep26717 · Cited by 715
The increasing threat of Pseudomonas aeruginosa high-risk clones
Oliver, A., Mulet, X., López-Causapé, C., & Juan, C. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.08.002 · Cited by 644
Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review
Pachori, P., Gothalwal, R., & Gandhi, P. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.04.001 · Cited by 620
Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives
Garneau-Tsodikova, S., & Labby, K. J. (2016) · MedChemComm · doi:10.1039/c5md00344j · Cited by 576
Bacterial stress responses as determinants of antimicrobial resistance
Poole, K. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks196 · Cited by 519
Self-citationCarmeli, Y., Armstrong, J., Laud, P. J., Newell, P., Stone, G., Wardman, A., & Gasink, L. B. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30004-4 · Cited by 417
Updates on the pathogenicity status of Pseudomonas aeruginosa
Azam, M. W., & Khan, A. U. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.07.003 · Cited by 374
Ayaz, M., Ullah, F., Sadiq, A., Ullah, F., Ovais, M., Ahmed, J., & Devkota, H. P. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.05.050 · Cited by 359
Influence of sulfate reduction rates on the Phanerozoic sulfur isotope record
Leavitt, W. D., Halevy, I., Bradley, A. S., & Johnston, D. T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218874110 · Cited by 352
Responses of Pseudomonas aeruginosa to antimicrobials
Morita, Y., Tomida, J., & Kawamura, Y. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00422 · Cited by 344
Plant growth promoting bacteria in agriculture: Two sides of a coin
Ramakrishna, W., Yadav, R., & Li, K. (2019) · Applied Soil Ecology · doi:10.1016/j.apsoil.2019.02.019 · Cited by 342
Elfadadny, A., Ragab, R. F., AlHarbi, M., Badshah, F., Ibáñez-Arancibia, E., Farag, A., Hendawy, A. O., De los Ríos-Escalante, P. R., Aboubakr, M., Zakai, S. A., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1374466 · Cited by 340
Liao, C., Huang, X., Wang, Q., Yao, D., & Lu, W. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.926758 · Cited by 309
Gao, Y., Wang, J., Chai, M., Li, X., Deng, Y., Jin, Q., & Ji, J. (2020) · ACS Nano · doi:10.1021/acsnano.0c00269 · Cited by 305
Liquid-Infused Silicone As a Biofouling-Free Medical Material
MacCallum, N., Howell, C., Kim, P., Sun, D., Friedlander, R., Ranisau, J., Ahanotu, O., Lin, J. J., Vena, A., Hatton, B., et al. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/ab5000578 · Cited by 289
RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition
Venter, H., Mowla, R., Ohene-Agyei, T., & Ma, S. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00377 · Cited by 285
The Resistome of Pseudomonas aeruginosa in Relationship to Phenotypic Susceptibility
Kos, V. N., Déraspe, M., McLaughlin, R. E., Whiteaker, J. D., Roy, P. H., Alm, R. A., Corbeil, J., & Gardner, H. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03954-14 · Cited by 264
Reighard, K. P., & Schoenfisch, M. H. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01208-15 · Cited by 49
Kin selection for cooperation in natural bacterial populations
Belcher, L. J., Dewar, A. E., Ghoul, M., & West, S. A. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119070119 · Cited by 36
Population Structure of Clinical Pseudomonas aeruginosa from West and Central African Countries
Cholley, P., Ka, R., Guyeux, C., Thouverez, M., Guessennd, N., Ghebremedhin, B., Frank, T., Bertrand, X., & Hocquet, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107008 · Cited by 31
A novel colistin adjuvant identified by virtual screening for ArnT inhibitors
Ghirga, F., Stefanelli, R., Cavinato, L., Lo Sciuto, A., Corradi, S., Quaglio, D., Calcaterra, A., Casciaro, B., Loffredo, M. R., Cappiello, F., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa200 · Cited by 28
Maslać, N., Sidhu, C., Teeling, H., & Wagner, T. (2022) · mBio · doi:10.1128/mbio.02443-22 · Cited by 18
Structural evolution of the ancient enzyme, dissimilatory sulfite reductase
Colman, D. R., Labesse, G., Swapna, G. V. T., Stefanakis, J., Montelione, G. T., Boyd, E. S., & Royer, C. A. (2022) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.26315 · Cited by 10
Metadata
- Authors
- Poole, K.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2011
- Volume
- 2
- Pages
- 65-65
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2057418340
- Cited by
- 948
- References
- 171
- FWCI
- 16.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.